6th

PHARMACOVIGILANCE
& DRUG SAFETY
CONFERENCE

Barcelona - Hotel TBA
27-28 April 2027
REGISTER NOW
6th
Edition
16+
Top pharma keynotes
20+
Sessions
2
Group stand-up discussions
1
Cocktail night
1
Dedicated app
2
Days in Barcelona
A

ABOUT THIS EVENT

AI, Real-World Data, and the Next Era of Pharmacovigilance

Pharmacovigilance is entering a new era. With the rise of AI, real-world evidence and evolving regulatory expectations, the demand for stronger and more innovative drug safety strategies has never been higher.

Join us at the 6th Pharmacovigilance & Drug Safety Conference on 27 and 28 April 2027 in Barcelona, hosted by UBIQ Events. The conference brings together pharmacovigilance experts, regulators and life sciences innovators to explore the latest trends, challenges and breakthroughs in drug safety, and to connect with the professionals shaping the future of the field.

Key focus areas include
01
Next-generation signal detection
02
AI in pharmacovigilance and case processing
03
Real-world data integration for drug safety
04
Global regulatory updates and compliance strategies
Where
Hotel TBA
Barcelona, Spain
When
27 to 28 April 2027
Tuesday to Wednesday
Register Now

Industry Leaders

The 2027 Speakers

Meet the voices driving the next generation of pharmacovigilance and drug safety.

The 6th Pharmacovigilance & Drug Safety Conference will feature an exceptional community of senior industry experts, regulatory authorities, and pioneering innovators, sharing insights on how the field is evolving in response to technological advances and changing regulatory expectations. Stay tuned as we unveil more speakers in the weeks ahead.
‍

Pav Rishiraj, Head of Pharmacovigilance at Ipsen

Pav Rishiraj

Head of Pharmacovigilance

Logo of Celltrion
Marta Munoz, Associate Director Patient Safety at AstraZeneca

Marta Munoz

Associate Director Patient Safety

Logo of Astrazeneca
Jean-Marc Häusler, Global Head International Patient Safety at Roche

Jean-Marc C. Häusler

Global Head International Patient Safety

Logo of Roche
Erika Barbarosie, Associate Director R&D Quality at Gilead Sciences

Erika Barbarosie

Associate Director R&D Quality

Logo of Gilead Sciences
Dimitris Zampatis, Director Product Patient Safety-TA Oncology and Immunology at Sandoz

Dimitris Zampatis

Global Program Safety Lead-Oncology

Novartis Logo
Reinhold Schilling, QPPPV at Wörwag Pharma

Reinhold Schilling

Head of Global Pharmacovigilance, QPPV

Wörwag Pharma Logo
Felix Arellano, Global Head of Pharmacovigilance and Drug Safety at Roche

Felix Arellano

Managing Director / Founder at Arellano Risk Management GmbH

Lizanne Pistorius, Head of Patient Safety & Pharmacovigilance at Boehringer Ingelheim

Lizanne Pistorius

Head of Patient Safety & Pharmacovigilance

logo of Boehringer Ingelheim

The 2026 Speakers

At the 5th Pharmacovigilance & Drug Safety Conference, we brought together a distinguished lineup of industry leaders, regulators, and innovators who are redefining drug safety in an era of rapid technological and regulatory change.
‍

Karsten Lollike, Scientific VP, Deputy QPPV at Global Patient Safety at Novo Nordisk
Karsten Lollike

Scientific VP and Deputy QPPV

Logo of Novo Nordisk
Pav Rishiraj, Head of Pharmacovigilance at Ipsen
Pav Rishiraj

Director, Head of Pharmacovigilance (UK)

Ipsen Logo
Heena Murarji, Director, Global PV Compliance & Business Management (GPV CBM), Otsuka
Heena Murarji

Director, Global PV Compliance & Business Management (GPV CBM)

Logo Pharmaceutical Otsuka
Jan Cleerbout, Deputy QPPV, Head of PV System Oversight at J&J
Jan Cleerbout

Deputy QPPV, Head of PV System Oversight

Logo Johnson & Johnson Innovative Medicine
Alex Bica, Global Head of Early Development and Translational Safety at CSL
Alex Bica

Global Head of Early Development and Translational Safety

Logo Pharmaceutical CSL
Felix Arellano, Global Head of Pharmacovigilance and Drug Safety at Roche
Felix Arellano

Global Head of Pharmacovigilance and Drug Safety

Logo Roche
Valentina Mancini, Senior Director Pharmacovigilance, QPPV at Shionogi
Valentina Mancini

Senior Director Pharmacovigilance, QPPV

Shionogi Logo
Dimitris Zampatis, Director Product Patient Safety-TA Oncology and Immunology at Sandoz
Dimitris Zampatis

Director Product Patient Safety-TA Oncology and Immunology

Iovance Biotherapeutics Logo
Matilde Solares, Associate Director, Global Pharmacovigilance Compliance at Otsuka
Matilde Solares

Associate Director, Global Pharmacovigilance Compliance and Business Management

Otsuka Logo
Jorgen Matz, Head, Global Clinical Quality & Pharmacovigilance at InsudPharma
Jorgen Matz

Head, Global Clinical Quality & Pharmacovigilance

Leo Pharma Logo
Luís Guedes, Global Product Safety Science Lead at Sobi
Luís Guedes

Global Product Safety Science Lead

Reinhold Schilling, QPPPV at Wörwag Pharma
Reinhold Schilling

Head of Global Pharmacovigilance, QPPV

Wörwag Pharma Logo
Beena Wood, Chief Product Officer at Qinecsa
Beena Wood

Chief Product Office

Qinecsa Solutions Logo
Romain Clément, CEO & Co-Founder at ArcaScience
Romain Clément

CEO & Co-Founder

ArcaScience Logo
Dr Maha Lakshmi Elluri, Global Safety Director, EU EEA QPPV at Indivior
Dr Maha Lakshmi Elluri

Global Safety Director, EU EEA QPPV

Sophie Besset-Dangla - VP, Head of Global Pharmacovigilance at Cencora
Sophie Besset-Dangla

VP, Head of Global Pharmacovigilance

Logo Cencora
Panagiota Grypioti

Safety Project Leader, Pharmacovigilance and Safety

Logo Cencora
Outstanding content

Key topics

A selection of the sessions that shaped the 2026 edition. The 2027 programme builds on these themes, with new speakers announced in the weeks ahead.

20+
Sessions
16+
Keynotes
2
Days
See the program
01
Practical Examples of Implementing AI Tools in Pharmacovigilance
02
Signal Management in the New AI Era
03
Mastering PV Excellence: Audit & Inspection Readiness in a Rapidly Evolving Landscape
04
AI-Integrated PV Operations: Automation, Oversight & Trust
05
Strengthening PV Through Smart Vendor Management
06
Patient-Centric Pharmacovigilance: Listening, Detecting & Acting Faster
07
Risk Management Plans 2.0: Proactive & Predictive Safety Strategies
08
Signal Detection at Scale: Leveraging RWE, Wearables & Non-Traditional Data
09
From Reaction to Anticipation: AI-Driven Benefit-Risk Intelligence for Next-Generation Drug Safety
10
Translational Safety Intelligence: Turning Preclinical Uncertainty Into Strategic Advantage
11
The Future PV Workforce: New Skills for an AI-Enabled Reality
12
Explainability Does Not Equal Safety: Lessons from Building AI for Pharmacovigilance
Ticket Pricing

Save your seat in Barcelona

Prices rise as the conference gets closer. Lock in the Early Bird rate and save up to 500€.

Current rate
Valid until 31 December 2026
Early Bird ticket
€690
€1,190
Save €500
Full access to both conference days, 27 to 28 April 2027
16+ top pharma keynotes
2 group stand-up discussions
Cocktail night
Networking lunches and coffee breaks
Dedicated conference app
Admit one
6th Pharmacovigilance & Drug Safety Conference
27 to 28 April 2027
Hotel TBA
Barcelona, Spain
Register now
Price timeline
Early Bird
€690
Until 31 Dec
January
€890
From 1 Jan
February
€990
From 1 Feb
March
€1,190
From 1 Mar
Industry Innovators

2Sponsors & Partners

The companies supporting the 6th Pharmacovigilance & Drug Safety Conference and the future of drug safety.

Gold sponsor
Bronze sponsor

Put your brand in front of PV leaders

Speaking slots, exhibition space and branding packages are available for 2027.

Become a sponsor
Ready to join us in Barcelona?
27-28 April 2027 · Barcelona · Early Bird rate valid until 31 December
get in touch

Contact our support team if you have more questions

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
get in touch

Let us Know
What Do You Have
in Mind

Interested on knowing more about the program, the venue, our sponsorship packages, the expected audience of this conference? Let us know!

Sponsorship Opportunities